Overview

Effect of Sulodexide in Early Diabetic Nephropathy

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether treatment with sulodexide is effective in reducing the level of urine albumin excretion in patients with early diabetic kidney disease expressed as microalbuminuria.
Phase:
Phase 3
Details
Lead Sponsor:
Keryx Biopharmaceuticals
Collaborator:
Collaborative Study Group (CSG)
Treatments:
Glucuronyl glucosamine glycan sulfate